Auteur R. P. J. KONING

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

4-Fluoroamphetamine in the Netherlands: more than a one-night stand

F. LINSEN ; R. P. J. KONING ; M. VAN LAAR ; R. J. M. NIESINK ; M. W. J. KOETER ; T. M. BRUNT | 2015
Dans Addiction (Vol.110, n°7, July 2015) Article : Périodique

Aims: To investigate the temporal pattern of appearance of a new psychoactive substance (4-fluoroamphetamine) on the Dutch drug market, as well as its patterns of use and effects. Design: Data from the Drug Information and Monitoring System (DI[...]

Plus d'info

Ajouter à la sélection

Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services

P. E. OOMEN ; D. SCHORI ; K. TOGEL-LINS ; D. ACREMAN ; S. CHENORHOKIAN ; A. LUF ; A. KARDEN ; C. PAULOS ; E. FORNERO ; E. GERACE ; R. P. J. KONING ; L. GALINDO ; L. A. SMIT-RIGTER ; F. MEASHAM ; M. VENTURA | 2022
Dans International Journal of Drug Policy (Vol.100, February 2022) Article : Périodique

Background: European drug checking services exchange information on drug trends within the Trans European Drug Information (TEDI) network, allowing monitoring and coordination of responses. Starting in Spring 2020, several services detected the [...]

Plus d'info

Ajouter à la sélection

Lien externe

Challenges, policy and politics in drug checking: reflections of the TEDItorial team

N. VAN DER LINDEN ; R. P. J. KONING ; D. VAN DER GOUWE ; M. VENTURA ; F. MEASHAM | 2022
Dans Drugs, Habits and Social Policy (Vol.23, n°3, 2022) Article : Périodique

Purpose: The purpose of this paper is to present some of the continued resistance and challenges faced by drug checking services (DCS) and review how the existing literature and the contributions to the special issue address them, with a view to[...]

Plus d'info

Ajouter à la sélection

Lien externe

Size matters: comparing the MDMA content and weight of ecstasy tablets submitted to European drug checking services in 2012-2021

R. Q. VROLIJK ; F. MEASHAM ; A. QUESADA ; A. LUF ; D. SCHORI ; S. RADLEY ; D. ACREMAN ; J. SMITH ; M. VERDENIK ; D. MARTINS ; M. CUNHA ; C. J. PAULOS ; I. F. PICCININ ; E. GERACE ; A. KARDEN ; R. P. J. KONING ; L. A. SMIT-RIGTER ; M. VENTURA | 2022
Dans Drugs, Habits and Social Policy (Vol.23, n°3, 2022) Article : Périodique

Purpose: The 3,4-methylenedioxymetamphetamine (MDMA) content in ecstasy tablets has increased enormously throughout Europe across the past decade. This study aims to determine whether this is caused by the production of "stronger" tablets (more [...]

Plus d'info

Ajouter à la sélection

Lien externe

Visitors of the Dutch drug checking services: Profile and drug use experience

R. P. J. KONING ; A. BENSCHOP ; C. WIJFFELS ; J. NOIJEN | 2021
Dans International Journal of Drug Policy (Vol.95, September 2021) Article : Périodique

Background Drug checking services (DCS) provide information about drug content and purity, alongside personalized feedback, to people who use drugs; however, the demographic and drug use characteristics of DCS clients are rarely reported. This p[...]

Plus d'info

Ajouter à la sélection

Lien externe